GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » ROA %

Neurotech International (ASX:NTI) ROA % : -28.10% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Neurotech International ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Neurotech International's annualized Net Income for the quarter that ended in Dec. 2023 was A$-1.46 Mil. Neurotech International's average Total Assets over the quarter that ended in Dec. 2023 was A$5.19 Mil. Therefore, Neurotech International's annualized ROA % for the quarter that ended in Dec. 2023 was -28.10%.

The historical rank and industry rank for Neurotech International's ROA % or its related term are showing as below:

ASX:NTI' s ROA % Range Over the Past 10 Years
Min: -466.76   Med: -182.59   Max: -77.46
Current: -77.46

During the past 7 years, Neurotech International's highest ROA % was -77.46%. The lowest was -466.76%. And the median was -182.59%.

ASX:NTI's ROA % is ranked worse than
87.83% of 863 companies
in the Medical Devices & Instruments industry
Industry Median: -2.04 vs ASX:NTI: -77.46

Neurotech International ROA % Historical Data

The historical data trend for Neurotech International's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International ROA % Chart

Neurotech International Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
ROA %
Get a 7-Day Free Trial -182.59 -466.76 -292.16 -95.66 -212.55

Neurotech International Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -89.77 -121.69 -129.32 -119.59 -28.10

Competitive Comparison of Neurotech International's ROA %

For the Medical Devices subindustry, Neurotech International's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurotech International's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neurotech International's ROA % distribution charts can be found below:

* The bar in red indicates where Neurotech International's ROA % falls into.



Neurotech International ROA % Calculation

Neurotech International's annualized ROA % for the fiscal year that ended in Jun. 2023 is calculated as:

ROA %=Net Income (A: Jun. 2023 )/( (Total Assets (A: Jun. 2022 )+Total Assets (A: Jun. 2023 ))/ count )
=-7.792/( (2.023+5.309)/ 2 )
=-7.792/3.666
=-212.55 %

Neurotech International's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-1.458/( (5.309+5.07)/ 2 )
=-1.458/5.1895
=-28.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Neurotech International  (ASX:NTI) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-1.458/5.1895
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-1.458 / 0.004)*(0.004 / 5.1895)
=Net Margin %*Asset Turnover
=-36450 %*0.0008
=-28.10 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Neurotech International ROA % Related Terms

Thank you for viewing the detailed overview of Neurotech International's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurotech International (ASX:NTI) Business Description

Traded in Other Exchanges
N/A
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Neurotech International (ASX:NTI) Headlines

From GuruFocus

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend 01-17-2013

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend 08-17-2013

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson 11-09-2013

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend 11-12-2014